Hey Waldo? Where's my $25? Is this the new math they teaching today? Down $25 or up $25 is the same thing. Funny how he has run so far away from even mentioning Vrtx. What a deutchbag.
qdelfan-I like this scenario. Let's say you are right and early approval takes place which causes shorts to massively cover in a short squeeze. 122.90 could pop to $150 in a scenario like that. Do you agree?
He's the Howard Cosell of fund prediction. I used to listen to him as a kid. He'd say "The Cowboys are beating the Redskins, as I predicted." Then later in the same game when the Redskins were beating the cowboys, he would say "As I predicted all along the Redskins are going to win."
Given the selloff by naysayers who are shorting VRTX after the ADCOM vote on Orakambi, (an overwhelmingly positive vote for the FDA's approval of this drug with 'breakthrough drug' designation) they are exposed to a possible early FDA approval. That, IMO, would lead to a huge short covering rally, which will be sustained by the pricing of Orakambi coming in at higher price than projected by the negative analysts, and the fact their is no competition for pharmacy benefit managers to demand excessive discounts from and a recent court decision regarding Kalydeco coverage for Medicaid CF patients in Arkansas making formulary exclusion of breakthrough drugs like Kalydeco and Orakambi illegal, and require health care insurers to pay for such drugs to insured CF patients with both public and private insurance.
You must be right. Everyone else I the world is wrong. I guess everyone will sell their $125 stock to buy your $4 stock now. What a deutchbag
It would be generous to give Cramer .5 batting average on any of his picks. Some of his other not so great picks were Alcoa, BOA, GoPro, Whole Foods,....etc. No telling how many got burned on this one.